GlucoWatch approved

WASHINGTON, March 22 (Reuters) - U.S. regulators said Thursday they approved
Cygnus Inc.’s <CYGN.O> GlucoWatch, a watch-like device that tracks blood sugar
levels in people with diabetes.

A spokeswoman for the Food and Drug Administration (FDA) said the agency
cleared the GlucoWatch for sale in the United States.

Closely watching blood sugar can help diabetics better manage their disease.

2 Responses to “GlucoWatch approved”

  1. Madge Bennie Says:

    (fyi) The GlucoWatch Biographer system uses an extremely low electric
    current to pull glucose through the skin. The glucose is then
    collected and converted into an electric signal that is converted
    into a glucose reading. The system consists of two integrated parts,
    the Biographer and the AutoSensor. The durable Biographer is worn
    like a watch and calculates, displays and stores glucose readings.
    The consumable AutoSensor is a single-use component that first
    collects and then converts the glucose into an electric signal. The
    AutoSensor snaps into the back of the Biographer and adheres to the
    skin, providing up to 12 hours of automatic readings.

  2. Randolph Fawn Says:

    I can’t stand anything that vibrates - even let go of the steering wheel when
    crossing the RR tracks. I doubt I could tolerate these electric currents going
    through my skin. I’ve lived 50 years with this and don’t need that now.
    Jan (~_^)

Leave a Reply

You must be logged in to post a comment.